2020 Q1 Form 10-Q Financial Statement

#000156459020022977 Filed on May 07, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $78.03M $70.58M
YoY Change 10.55% 51.92%
Cost Of Revenue $29.04M $28.20M
YoY Change 2.99% 77.92%
Gross Profit $48.99M $42.38M
YoY Change 15.58% 38.46%
Gross Profit Margin 62.78% 60.05%
Selling, General & Admin $35.10M $22.32M
YoY Change 57.28% -49.83%
% of Gross Profit 71.66% 52.66%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.145M $2.808M
YoY Change 47.61% 40.4%
% of Gross Profit 8.46% 6.63%
Operating Expenses $88.76M $65.60M
YoY Change 35.32% 47.44%
Operating Profit -$39.78M -$23.21M
YoY Change 71.35% 67.25%
Interest Expense $20.00K $131.0K
YoY Change -84.73% -219.09%
% of Operating Profit
Other Income/Expense, Net $8.000K -$282.0K
YoY Change -102.84% 156.36%
Pretax Income -$38.50M -$23.22M
YoY Change 65.8% 64.58%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$38.50M -$23.22M
YoY Change 65.8% 64.62%
Net Earnings / Revenue -49.35% -32.9%
Basic Earnings Per Share
Diluted Earnings Per Share -$444.6K -$280.8K
COMMON SHARES
Basic Shares Outstanding 86.53M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $303.3M $103.0M
YoY Change 194.47%
Cash & Equivalents $134.7M $88.79M
Short-Term Investments $168.6M $14.20M
Other Short-Term Assets $11.30M $12.10M
YoY Change -6.61%
Inventory $24.90M $10.50M
Prepaid Expenses
Receivables $3.100M $11.30M
Other Receivables $0.00 $0.00
Total Short-Term Assets $342.5M $136.9M
YoY Change 150.18%
LONG-TERM ASSETS
Property, Plant & Equipment $184.0M $35.20M
YoY Change 422.73%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.000M $14.90M
YoY Change -79.87%
Total Long-Term Assets $187.0M $50.20M
YoY Change 272.51%
TOTAL ASSETS
Total Short-Term Assets $342.5M $136.9M
Total Long-Term Assets $187.0M $50.20M
Total Assets $529.5M $187.1M
YoY Change 183.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.900M $5.200M
YoY Change 90.38%
Accrued Expenses $87.90M $75.30M
YoY Change 16.73%
Deferred Revenue $3.690M
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $5.800M
YoY Change
Total Short-Term Liabilities $101.6M $90.30M
YoY Change 12.51%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $2.500M
YoY Change -100.0%
Other Long-Term Liabilities $121.2M $7.900M
YoY Change 1434.18%
Total Long-Term Liabilities $121.2M $10.40M
YoY Change 1065.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $101.6M $90.30M
Total Long-Term Liabilities $121.2M $10.40M
Total Liabilities $222.8M $100.7M
YoY Change 121.25%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $304.9M -$281.0M
YoY Change
Total Liabilities & Shareholders Equity $529.5M $187.1M
YoY Change 183.0%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income -$38.50M -$23.22M
YoY Change 65.8% 64.62%
Depreciation, Depletion And Amortization $4.145M $2.808M
YoY Change 47.61% 40.4%
Cash From Operating Activities -$54.97M -$22.57M
YoY Change 143.55% 50.77%
INVESTING ACTIVITIES
Capital Expenditures $6.486M $3.743M
YoY Change 73.28% -216.97%
Acquisitions
YoY Change
Other Investing Activities $40.74M $12.87M
YoY Change 216.55% 3.71%
Cash From Investing Activities $32.77M $7.444M
YoY Change 340.27% -19.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.413M 69.71M
YoY Change -96.54% -9918.45%
NET CHANGE
Cash From Operating Activities -54.97M -22.57M
Cash From Investing Activities 32.77M 7.444M
Cash From Financing Activities 2.413M 69.71M
Net Change In Cash -19.78M 54.58M
YoY Change -136.25% -943.65%
FREE CASH FLOW
Cash From Operating Activities -$54.97M -$22.57M
Capital Expenditures $6.486M $3.743M
Free Cash Flow -$61.46M -$26.31M
YoY Change 133.55% 123.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-26577000
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.44
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.05
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
86588796
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
8705664
CY2020Q1 real Operations And Technology Expense
OperationsAndTechnologyExpense
40737000
CY2019Q1 real Operations And Technology Expense
OperationsAndTechnologyExpense
31544000
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
35104000
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
22319000
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
88763000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
65596000
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
699249000
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
86850694
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
86850694
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
78239000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
70582000
CY2020Q1 us-gaap Cost Of Revenue
CostOfRevenue
29042000
CY2019Q1 us-gaap Cost Of Revenue
CostOfRevenue
28200000
CY2020Q1 us-gaap Gross Profit
GrossProfit
49197000
CY2019Q1 us-gaap Gross Profit
GrossProfit
42382000
CY2020Q1 us-gaap Marketing Expense
MarketingExpense
12922000
CY2019Q1 us-gaap Marketing Expense
MarketingExpense
11733000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-39566000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-23214000
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1286000
CY2019Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
405000
CY2020Q1 real Reduction Of Operating Lease Right Of Use Assets
ReductionOfOperatingLeaseRightOfUseAssets
4121000
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
455000
CY2019Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
321000
CY2019Q1 real Compensation Expense Related To Stock Sales By Current And Former Employees
CompensationExpenseRelatedToStockSalesByCurrentAndFormerEmployees
819000
CY2020Q1 us-gaap Interest Expense
InterestExpense
20000
CY2019Q1 us-gaap Interest Expense
InterestExpense
131000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8000
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-282000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-38292000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23222000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-38292000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-23222000
CY2019Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
3355000
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-38292000
CY2020Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
314000
CY2019Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
28000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-37978000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23194000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2564000
CY2020Q1 real Stock Issued During Period Value Common Stock Upon Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes
StockIssuedDuringPeriodValueCommonStockUponVestingOfRestrictedStockUnitsNetOfSharesWithheldForEmployeeTaxes
-151000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3410000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
314000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-257690000
CY2019Q1 real Accretion Of Redeemable Convertible Preferred Stock To Redemption Value Adjustments
AccretionOfRedeemableConvertiblePreferredStockToRedemptionValueAdjustments
-3355000
CY2019Q1 real Adjustments To Additional Paid In Capital Share Based Compensation Related To Stock Sales By Current Employees
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRelatedToStockSalesByCurrentEmployees
819000
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1319000
CY2019Q1 real Stock Issued During Period Value Warrant Exercised
StockIssuedDuringPeriodValueWarrantExercised
13000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1109000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
28000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-280979000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-38292000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-23222000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4145000
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2808000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3410000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1109000
CY2019Q1 real Change In Fair Value Of Convertible Preferred Stock Warrant Liability
ChangeInFairValueOfConvertiblePreferredStockWarrantLiability
280000
CY2020Q1 real Accretion Of Unconditional Endowment Grant Liability
AccretionOfUnconditionalEndowmentGrantLiability
23000
CY2019Q1 real Accretion Of Unconditional Endowment Grant Liability
AccretionOfUnconditionalEndowmentGrantLiability
26000
CY2019Q1 real Accretion Of Debt Discounts
AccretionOfDebtDiscounts
7000
CY2020Q1 real Amortization Of Premiums Discounts On Short Term Investments
AmortizationOfPremiumsDiscountsOnShortTermInvestments
207000
CY2019Q1 real Amortization Of Premiums Discounts On Short Term Investments
AmortizationOfPremiumsDiscountsOnShortTermInvestments
-40000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4235000
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4050000
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1317000
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
173000
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2356000
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2388000
CY2020Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
365000
CY2019Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
111000
CY2020Q1 real Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
2721000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2206000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
797000
CY2020Q1 real Increase Decrease In Accrued Consignor Payable
IncreaseDecreaseInAccruedConsignorPayable
-19331000
CY2019Q1 real Increase Decrease In Accrued Consignor Payable
IncreaseDecreaseInAccruedConsignorPayable
1292000
CY2020Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-8865000
CY2019Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-475000
CY2020Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-412000
CY2019Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
349000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-54971000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22571000
CY2020Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
73280000
CY2020Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
114020000
CY2019Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
12873000
CY2020Q1 us-gaap Payments For Software
PaymentsForSoftware
1480000
CY2019Q1 us-gaap Payments For Software
PaymentsForSoftware
1686000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6486000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3743000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
32774000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
7444000
CY2019Q1 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
43572000
CY2019Q1 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
26279000
CY2020Q1 real Proceeds From Stock Options Exercised And Common Stock Warrants
ProceedsFromStockOptionsExercisedAndCommonStockWarrants
2564000
CY2019Q1 real Proceeds From Stock Options Exercised And Common Stock Warrants
ProceedsFromStockOptionsExercisedAndCommonStockWarrants
1332000
CY2019Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
222000
CY2020Q1 real Payments Related To Tax Withholding For Restricted Stock Vesting
PaymentsRelatedToTaxWithholdingForRestrictedStockVesting
151000
CY2019Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
1250000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2413000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
69711000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-19784000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
54584000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
154446000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
45627000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
134662000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
100211000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
4000
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
98000
CY2019Q1 real Accretion Of Redeemable Convertible Preferred Stock To Redemption Value
AccretionOfRedeemableConvertiblePreferredStockToRedemptionValue
3355000
CY2020Q1 real Purchase Of Property And Equipment Included In Accounts Payable And Other Current Liabilities
PurchaseOfPropertyAndEquipmentIncludedInAccountsPayableAndOtherCurrentLiabilities
-771000
CY2019Q1 real Purchase Of Property And Equipment Included In Accounts Payable And Other Current Liabilities
PurchaseOfPropertyAndEquipmentIncludedInAccountsPayableAndOtherCurrentLiabilities
-704000
CY2020Q1 real Purchases Of Capitalized Proprietary Software Development Costs Included In Accounts Payable And Other Current Liabilities
PurchasesOfCapitalizedProprietarySoftwareDevelopmentCostsIncludedInAccountsPayableAndOtherCurrentLiabilities
756000
CY2019Q1 real Deferred Offering Costs In Accounts Payable And Accrued Liabilities
DeferredOfferingCostsInAccountsPayableAndAccruedLiabilities
1457000
CY2020Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of expenses during the reporting period. Significant items subject to such estimates and assumptions include those related to revenue recognition, including the returns reserve and material right related to the Company&#8217;s tiered consignor commission plan, valuation of inventory, stock-based compensation, redemption value of redeemable convertible preferred stock, incremental borrowing rates related to lease liability, and other contingencies. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;color:#212529;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">The Company is not presently aware of any events or circumstances arising from the COVID-19 pandemic that would require it to update its estimates, assumptions or revise the carrying value of its assets or liabilities. Its estimates may change, however, as new events occur and additional information is obtained; any such changes will be recognized in the financial statements. Actual results could differ from estimates, and any such differences may be material to the financial statements.</font></p>
CY2020Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Concentrations of Credit Risks </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash and cash equivalents, accounts receivable, and investments. At times, such amount may exceed federally-insured limits. The Company reduces credit risk by placing its cash and cash equivalents, restricted cash and investments with major financial institutions within the United States. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of March 31, 2020 and December 31, 2019, there were no customers that represented 10% or more of the Company&#8217;s accounts receivable balance and there were no customers that individually exceeded 10% of the&#160;Company&#8217;s total revenue for each of the three months ended March 31, 2020 and 2019. </p>
CY2019 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2020Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
88790000
CY2019Q1 us-gaap Restricted Cash
RestrictedCash
11421000
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
110300000
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12800000
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
106200000
CY2020Q1 real Cash And Cash Equivalents Amortized Cost
CashAndCashEquivalentsAmortizedCost
134641000
CY2020Q1 real Cash And Cash Equivalents Gross Unrealized Gains
CashAndCashEquivalentsGrossUnrealizedGains
21000
CY2020Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
134662000
CY2020Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
168291000
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
526000
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
225000
CY2019Q4 real Cash And Cash Equivalents Amortized Cost
CashAndCashEquivalentsAmortizedCost
154446000
CY2019Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
154446000
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
208804000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
14000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
7000
CY2020Q1 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2019Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q1 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2019Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2019 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2020Q1 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2019Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2020Q1 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2019Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2020Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2019 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2020Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2019 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2020Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
96100000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
88624000
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
36463000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
32793000
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4100000
CY2019Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2800000
CY2020Q1 real Accrued Returns Reserve Current
AccruedReturnsReserveCurrent
10662000
CY2019Q4 real Accrued Returns Reserve Current
AccruedReturnsReserveCurrent
17005000
CY2020Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
8745000
CY2019Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
11626000
CY2020Q1 real Site Credit Liability
SiteCreditLiability
5784000
CY2019Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
19610000
CY2019Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
18307000
CY2019Q4 real Site Credit Liability
SiteCreditLiability
5080000
CY2020Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
3984000
CY2019Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
6132000
CY2020Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3690000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4767000
CY2020Q1 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
8728000
CY2019Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
6830000
CY2020Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2348000
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3127000
CY2020Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
0
CY2019Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
100000
CY2020Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0
CY2019Q1 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
115185867
CY2019Q1 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
114960357
CY2019Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
367406000
CY2019Q1 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
376007000
CY2019Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
114960357
CY2020Q1 real Share Based Compensation Expense Excludes Share Based Compensation Related To Stock Sales By Current And Former Employees
ShareBasedCompensationExpenseExcludesShareBasedCompensationRelatedToStockSalesByCurrentAndFormerEmployees
3410000
CY2019Q1 real Share Based Compensation Expense Excludes Share Based Compensation Related To Stock Sales By Current And Former Employees
ShareBasedCompensationExpenseExcludesShareBasedCompensationRelatedToStockSalesByCurrentAndFormerEmployees
1109000
CY2020Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
6000000
CY2019Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
4100000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
16603000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
24123000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
21464000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
20087000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
19678000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
71506000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
173461000
CY2020Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
39078000
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
134383000
CY2019Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
20530000
CY2019Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
22059000
CY2019Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
17957000
CY2019Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
67208000
CY2019Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
165671000
CY2020Q1 real Cash Paid For Amounts Included In Measurement Of Lease Liabilities
CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities
4597000
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
18122000
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y10M24D
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.068
CY2020Q1 real Grant Liability
GrantLiability
500000
CY2019Q4 real Grant Liability
GrantLiability
900000
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9741022
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
67677239

Files In Submission

Name View Source Status
0001564590-20-022977-index-headers.html Edgar Link pending
0001564590-20-022977-index.html Edgar Link pending
0001564590-20-022977.txt Edgar Link pending
0001564590-20-022977-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
real-10q_20200331.htm Edgar Link pending
real-20200331.xml Edgar Link completed
real-20200331.xsd Edgar Link pending
real-20200331_cal.xml Edgar Link unprocessable
real-20200331_def.xml Edgar Link unprocessable
real-20200331_lab.xml Edgar Link unprocessable
real-20200331_pre.xml Edgar Link unprocessable
real-ex311_8.htm Edgar Link pending
real-ex312_7.htm Edgar Link pending
real-ex321_6.htm Edgar Link pending
real-ex322_9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending